Skogeland, Ulrika
de Monestrol, Isabelle
Pincikova, Terezia
Godskesen, Tove
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 11 October 2024
Accepted: 28 January 2025
First Online: 3 February 2025
Declarations
:
: The study was approved by the Swedish Ethical Review Authority (reference number: 2022-03456-01). Furthermore, the Director of the Medical Unit and the Heads of Sections responsible for the CF teams in Stockholm and Uppsala granted their approval. The research adhered to the ethical principles for medical research in line with the Declaration of Helsinki [] and compiled with the EU Data Protection Regulation (EU, 2016:679) []. All participants were informed about the aim of the study, their right to withdraw at any time without consequences, and the confidentiality of their data. The participants were also informed that personal information would be kept confidential. All participants gave written consent before the data collection started.
: Not applicable.
: The authors declare no competing interests.